The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarclays Regulatory News (BARC)

Share Price Information for Barclays (BARC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 204.45
Bid: 204.45
Ask: 204.50
Change: 13.31 (6.96%)
Spread: 0.05 (0.024%)
Open: 195.96
High: 205.45
Low: 194.00
Prev. Close: 191.14
BARC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - TAKEDA

7 Dec 2018 14:14

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 06 December 2018
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? SHIRE PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary NPV
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 12,088,609 1.52% 13,433,355 1.69%
(2) Cash-settled derivatives:
13,103,638 1.65% 10,881,300 1.37%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 10,521,600 1.32% 10,941,600 1.38%
(4)
TOTAL: 35,713,847 4.49% 35,256,255 4.44%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ADR Purchase 12,142 17.7965 USD
ADR Purchase 13,000 17.4933 USD
ADR Purchase 14,873 17.7150 USD
ADR Purchase 28,342 17.5715 USD
ADR Purchase 40,000 17.6000 USD
ADR Purchase 50,000 17.7400 USD
ADR Purchase 64,837 17.5107 USD
ADR Purchase 75,510 17.5598 USD
ADR Purchase 106,326 17.6552 USD
ADR Purchase 250,000 17.5260 USD
ADR Sale 1,028 17.6500 USD
ADR Sale 6,500 17.4933 USD
ADR Sale 12,142 17.7965 USD
ADR Sale 14,873 17.7150 USD
ADR Sale 28,342 17.5715 USD
ADR Sale 30,000 17.4667 USD
ADR Sale 40,000 17.6000 USD
ADR Sale 42,178 17.4928 USD
ADR Sale 75,510 17.5597 USD
ADR Sale 250,000 17.5260 USD
Ordinary NPV Purchase 33 4,126.4200 JPY
Ordinary NPV Purchase 36 4,141.6944 JPY
Ordinary NPV Purchase 100 4,123.0000 JPY
Ordinary NPV Purchase 191 4,109.0262 JPY
Ordinary NPV Purchase 400 4,126.5750 JPY
Ordinary NPV Purchase 559 4,121.8872 JPY
Ordinary NPV Purchase 600 4,100.0000 JPY
Ordinary NPV Purchase 724 4,124.3618 JPY
Ordinary NPV Purchase 836 4,117.7428 JPY
Ordinary NPV Purchase 894 4,123.1991 JPY
Ordinary NPV Purchase 1,300 4,141.1838 JPY
Ordinary NPV Purchase 2,600 4,123.9538 JPY
Ordinary NPV Purchase 2,900 4,125.1379 JPY
Ordinary NPV Purchase 3,000 4,110.7266 JPY
Ordinary NPV Purchase 3,200 4,104.0000 JPY
Ordinary NPV Purchase 3,363 4,111.6693 JPY
Ordinary NPV Purchase 3,900 4,115.1589 JPY
Ordinary NPV Purchase 4,000 4,139.6500 JPY
Ordinary NPV Purchase 4,169 4,125.0309 JPY
Ordinary NPV Purchase 4,887 4,119.7215 JPY
Ordinary NPV Purchase 5,100 4,119.1764 JPY
Ordinary NPV Purchase 5,200 4,131.7211 JPY
Ordinary NPV Purchase 5,800 4,124.8103 JPY
Ordinary NPV Purchase 6,369 4,120.1135 JPY
Ordinary NPV Purchase 6,600 4,111.2878 JPY
Ordinary NPV Purchase 7,300 4,112.3424 JPY
Ordinary NPV Purchase 8,500 4,123.9352 JPY
Ordinary NPV Purchase 20,100 4,130.3631 JPY
Ordinary NPV Purchase 24,200 4,110.0165 JPY
Ordinary NPV Purchase 30,739 4,115.4911 JPY
Ordinary NPV Purchase 58,800 4,125.5578 JPY
Ordinary NPV Purchase 143,200 4,123.8805 JPY
Ordinary NPV Purchase 194,100 4,114.3307 JPY
Ordinary NPV Purchase 430,500 4,122.6125 JPY
Ordinary NPV Purchase 746,800 4,125.1037 JPY
Ordinary NPV Purchase 749,600 4,125.6579 JPY
Ordinary NPV Sale 100 4,123.0000 JPY
Ordinary NPV Sale 200 4,104.0000 JPY
Ordinary NPV Sale 200 4,112.0000 JPY
Ordinary NPV Sale 600 4,125.0000 JPY
Ordinary NPV Sale 800 4,111.6250 JPY
Ordinary NPV Sale 2,600 4,123.9538 JPY
Ordinary NPV Sale 2,900 4,125.1379 JPY
Ordinary NPV Sale 3,300 4,136.1818 JPY
Ordinary NPV Sale 3,400 4,112.5911 JPY
Ordinary NPV Sale 3,500 4,127.6571 JPY
Ordinary NPV Sale 3,900 4,115.1589 JPY
Ordinary NPV Sale 4,000 4,133.8750 JPY
Ordinary NPV Sale 5,200 4,131.9038 JPY
Ordinary NPV Sale 5,800 4,124.8103 JPY
Ordinary NPV Sale 6,700 4,109.9402 JPY
Ordinary NPV Sale 7,100 4,112.3521 JPY
Ordinary NPV Sale 8,500 4,123.9352 JPY
Ordinary NPV Sale 11,800 4,120.2923 JPY
Ordinary NPV Sale 11,900 4,103.4873 JPY
Ordinary NPV Sale 17,500 4,110.0457 JPY
Ordinary NPV Sale 25,500 4,137.1568 JPY
Ordinary NPV Sale 25,700 4,104.1400 JPY
Ordinary NPV Sale 81,400 4,110.6646 JPY
Ordinary NPV Sale 143,200 4,123.1920 JPY
Ordinary NPV Sale 746,800 4,125.1037 JPY
Ordinary NPV Sale 753,600 4,125.5563 JPY
Ordinary NPV Sale 1,106,700 4,121.9396 JPY

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
Ordinary NPV CFD Long 159,900 4,125.3009 JPY
Ordinary NPV CFD Long 160,100 4,125.3573 JPY
Ordinary NPV SWAP Expires 13/12/2018 Long 339,100 4,141.0000 JPY
Ordinary NPV SWAP Short 12 4,131.5183 JPY
Ordinary NPV SWAP Short 24 4,119.4026 JPY
Ordinary NPV SWAP Short 25 4,133.1218 JPY
Ordinary NPV SWAP Short 33 4,126.4126 JPY
Ordinary NPV SWAP Short 36 4,141.7474 JPY
Ordinary NPV SWAP Short 58 4,131.7407 JPY
Ordinary NPV SWAP Short 91 4,117.5268 JPY
Ordinary NPV SWAP Short 107 4,127.1933 JPY
Ordinary NPV SWAP Short 110 4,129.1256 JPY
Ordinary NPV SWAP Short 191 4,109.0304 JPY
Ordinary NPV SWAP Short 200 4,121.5000 JPY
Ordinary NPV SWAP Short 400 4,119.0000 JPY
Ordinary NPV SWAP Short 547 4,121.6760 JPY
Ordinary NPV SWAP Short 699 4,124.0502 JPY
Ordinary NPV SWAP Short 812 4,117.6941 JPY
Ordinary NPV SWAP Short 836 4,122.6081 JPY
Ordinary NPV SWAP Short 1,300 4,141.1842 JPY
Ordinary NPV SWAP Short 1,572 4,132.8659 JPY
Ordinary NPV SWAP Short 3,363 4,111.6697 JPY
Ordinary NPV SWAP Short 4,059 4,124.9203 JPY
Ordinary NPV SWAP Short 4,780 4,119.5541 JPY
Ordinary NPV SWAP Short 6,278 4,120.1513 JPY
Ordinary NPV SWAP Short 29,167 4,114.5546 JPY
Ordinary NPV SWAP Expires 06/12/2018 Short 339,100 4,562.0000 JPY

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 7 Dec 2018
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN OPTION AND DERIVATIVE POSITIONS, AGREEMENTS TO

PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

1. KEY INFORMATION
Identity of the person whose positions/dealings Barclays PLC.
are being disclosed:
Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this from relates:
2. OPTIONS AND DERIVATIVES
Class Product Writing, Number Exercise Type Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
relates
Ordinary NPV Call Options Purchased 39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Purchased 40,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -460,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Written -104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Call Options Written -78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Call Options Written -70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Purchased -39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Written 75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Put Options Written 78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Put Options Written 114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Purchased 10,000,000 4206.0397 European 7 Jan 2019
Ordinary NPV Call Options Written -10,000,000 4206.0397 European 7 Jan 2019
Ordinary NPV Put Options Purchased -10,000,000 4206.0397 European 7 Jan 2019
Ordinary NPV Put Options Written 10,000,000 4206.0397 European 7 Jan 2019
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the interest or position can be fully
understood:

View source version on businesswire.com: https://www.businesswire.com/news/home/20181207005240/en/

Copyright Business Wire 2018

Date   Source Headline
25th Apr 20242:45 pmRNSForm 8.3 - Wincanton plc
25th Apr 20242:43 pmRNSForm 8.3 - Virgin Money UK plc
25th Apr 20242:41 pmRNSForm 8.3 - UK Commercial Property REIT Limited
25th Apr 20242:40 pmRNSForm 8.3 - Tritax Big Box REIT plc
25th Apr 20242:38 pmRNSForm 8.3 - Spirent Communications plc
25th Apr 20242:36 pmRNSForm 8.3 - Tyman plc
25th Apr 20242:34 pmRNSForm 8.3 - Quanex Building Products Corporation
25th Apr 20242:32 pmRNSForm 8.3 - Network International Holdings plc
25th Apr 20242:30 pmRNSForm 8.3 - Mattioli Woods plc
25th Apr 20242:18 pmRNSForm 8.3 - Lok’n Store Group plc
25th Apr 20242:16 pmRNSForm 8.3 - Kin and Carta plc
25th Apr 20242:13 pmRNSForm 8.3 - International Paper Company
25th Apr 20242:12 pmRNSForm 8.3 - Smith (DS) plc
25th Apr 202410:48 amRNSForm 38.5(b)-Irish Residential Properties REIT plc
25th Apr 202410:46 amRNSForm 8.5(EPT/NON-RI)-International Distribut Serv
25th Apr 202410:43 amRNSForm 8.5(EPT/NON-RI)-GCP Asset Backed Income F Ltd
25th Apr 202410:42 amRNSForm 8.5 (EPT/NON-RI) - Redrow plc
25th Apr 202410:41 amRNSForm 8.5 (EPT/NON-RI) - Barratt Developments plc
25th Apr 202410:39 amRNSForm 8.5 (EPT/NON-RI)-Balanced Commercial Prop Tru
25th Apr 20247:30 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNS1st Quarter Results
24th Apr 20246:29 pmRNSDisposal of Italian mortgage portfolio
24th Apr 20242:41 pmRNSForm 8.3 - Wincanton plc
24th Apr 20242:39 pmRNSForm 8.3 - Virgin Money UK plc
24th Apr 20242:38 pmRNSForm 8.3 - UK Commercial Property REIT Limited
24th Apr 20242:36 pmRNSForm 8.3 - Tritax Big Box REIT plc
24th Apr 20242:34 pmRNSForm 8.3 - Spirent Communications plc
24th Apr 20242:32 pmRNSForm 8.3 - Tyman plc
24th Apr 20242:31 pmRNSForm 8.3 - Quanex Building Products Corporation
24th Apr 20242:29 pmRNSForm 8.3 - Network International Holdings plc
24th Apr 20242:28 pmRNSForm 8.3 - Mattioli Woods plc
24th Apr 20242:26 pmRNSForm 8.3 - Lok’n Store Group plc
24th Apr 20242:24 pmRNSForm 8.3 - International Paper Company
24th Apr 20242:22 pmRNSForm 8.3 - Smith (DS) plc
24th Apr 202411:20 amRNSForm 38.5(b)-Irish Residential Properties REIT plc
24th Apr 202411:16 amRNSForm 8.5(EPT/NON-RI)-International Distribut Serv
24th Apr 202411:13 amRNSForm 8.5(EPT/NON-RI)-GCP Asset Backed Income F Ltd
24th Apr 202411:12 amRNSForm 8.5 (EPT/NON-RI) - Redrow plc
24th Apr 202411:12 amRNSForm 8.5 (EPT/NON-RI) - Barratt Developments plc
24th Apr 202411:11 amRNSForm 8.5 (EPT/NON-RI)-Balanced Commercial Prop Tru
24th Apr 20247:30 amRNSTransaction in Own Shares
23rd Apr 20243:26 pmRNSForm 8.3 - WINCANTON PLC
23rd Apr 20243:26 pmRNSForm 8.3 - VIRGIN MONEY UK PLC
23rd Apr 20243:26 pmRNSForm 8.3 - TYMAN PLC
23rd Apr 20243:26 pmRNSForm 8.3 - UK COMMERCIAL PROPERTY REIT LTD
23rd Apr 20243:26 pmRNSForm 8.3 - QUANEX BUILDING PRODUCTS CORP
23rd Apr 20243:26 pmRNSForm 8.3 - TRITAX BIG BOX REIT PLC
23rd Apr 20243:25 pmRNSForm 8.3 - SPIRENT COMMUNICATIONS PLC
23rd Apr 20243:25 pmRNSForm 8.3 - INTERNATIONAL PAPER CO
23rd Apr 20243:25 pmRNSForm 8.3 - NETWORK INTERNATIONAL HOLDINGS PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.